<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:department>Therapeutics</gtr:department><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/77558636-602F-416D-9BB4-73B783769BC3"><gtr:id>77558636-602F-416D-9BB4-73B783769BC3</gtr:id><gtr:name>Pfizer Ltd</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/B6B6213D-3EDE-4C40-A6BE-6E8F2CB9048A"><gtr:id>B6B6213D-3EDE-4C40-A6BE-6E8F2CB9048A</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Hall</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0701390"><gtr:id>E5F797F8-7BB7-4384-82A0-E651B13D9C39</gtr:id><gtr:title>What controls calcium homeostasis in human airway smooth muscle?</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0701390</gtr:grantReference><gtr:abstractText>Asthma is a major cause of lost working days in the UK: currently, according to Asthma UK 5.2 million are taking asthma treatment. The majority of symptoms are caused by narrowing of the airways. A major component of airway narrowing is due to contraction of the muscle (called airway smooth muscle) in the airway wall. This contraction is due to calcium release within the muscle cell or entry of calcium into the muscle cell. The mechanisms underlying these responses are poorly understood. This project will systematically define the important pathways and signalling molecules responsible for these processes. By defining these mechanisms, it should be feasible to design new treatments for asthma. We will also gain a fuller understanding of the mechanisms underlying the development of asthma.</gtr:abstractText><gtr:technicalSummary>Short term changes in the calibre of the human airway are primarily influenced by the tone of the airway smooth muscle (ASM) bundles found in the airway wall. Contraction of ASM produces bronchoconstriction. In contrast relaxation produces bronchodilation, a response which underlies the mechanism of action of beta2 adrenoceptor agonists, the most widely used agents for symptom relief in asthma and COPD. Thus understanding the mechanisms underlying contraction and relaxation of the ASM cell is critical to the study of the pathophysiology of airway disease. Recent studies including those by the applicant using siRNA and other approaches has led to the recognition of Ca2+ homeostasis being fundamental to these processes. The hypotheses to be examined in this programme of work are therefore as follow:

(i) contraction of airway smooth muscle (ASM) is dependent upon Ca2+ entry via both receptor and store dependent pathways
(ii) signalling of Ca2+ entry into ASM following store depletion is mediated by STIM1 and Orai1 induced activation of as yet undefined Ca2+ entry channels
(iii) agonist induced Ca2+ entry is dependent in part on store dependent pathways but also involves separate, receptor activated pathways, involving trp channels and related homologues
(iv) using a systematic siRNA based approach in a range of physiologically relevant model systems including human primary cultured cell and lung slice models these pathways can be defined
To address the role of these pathways in ASM contraction, we will (i) delineate Ca2+ entry pathways in primary cultured human ASM cells using both measurement of intracellular Ca2+ and electrophysiological (patch clamp) approaches, and (ii) delineate the contribution of these pathways to ASM contraction using lung slice preparations from murine and human lung to simultaneously monitor ASM Ca2+ oscillations and contractile responses. Inhibition of components potentially important in contractile signalling will be achieved by use of selective antagonists (where available), siRNA approaches using a panel of characterised siRNA species we are developing and with which we have undertaken preliminary proof of principle work, and exploratory screening using two siRNA libraries targeted at ion channels and Ca2+ signalling pathways.</gtr:technicalSummary><gtr:fund><gtr:end>2011-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>328156</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Nottingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Mathematical Sciences Nottingham</gtr:department><gtr:description>University of nottingham Mathematical modelling group</gtr:description><gtr:id>0D7C165B-5F3D-4091-AB0E-06F649B4459C</gtr:id><gtr:impact>See above: recently awarded NRC NIRG to Dr Brook.</gtr:impact><gtr:partnerContribution>Provision of in vitro model system to allow modelling work to be validated</gtr:partnerContribution><gtr:piContribution>Collaboration on paper (listed above) resulting in new investigator grant to Dr B Brook.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Pfizer Ltd</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>functional genetics of COPD</gtr:description><gtr:id>37CE7CFB-F416-4BF7-8173-2D46E2C978D0</gtr:id><gtr:impact>none yet (about to commence)</gtr:impact><gtr:partnerContribution>access to novel agents</gtr:partnerContribution><gtr:piContribution>Methods developed during this grant have led (in conjunction with work on population genetics) to a funded research collaboration with Pfizer (value ~ &amp;pound;380k)</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>180000</gtr:amountPounds><gtr:country>Germany, Federal Republic of</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Boehringer Ingelheim</gtr:department><gtr:description>industry collaboration,</gtr:description><gtr:end>2017-10-02</gtr:end><gtr:fundingOrg>C.H. Boehringer Sohn AG &amp; Ko. KG</gtr:fundingOrg><gtr:id>EB80D60C-F983-4BF8-9CE5-9671B6F8A739</gtr:id><gtr:sector>Private</gtr:sector><gtr:start>2016-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NC3Rs consultation on animal models and lung disease</gtr:description><gtr:geographicReach>Asia</gtr:geographicReach><gtr:id>DF448EC9-6A40-4344-8AD9-8AD9AC29F922</gtr:id><gtr:type>Participation in a national consultation</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/16901C7B-CAC4-4A02-8B39-20A04E95C04E"><gtr:id>16901C7B-CAC4-4A02-8B39-20A04E95C04E</gtr:id><gtr:title>ORAI and store-operated calcium influx in human airway smooth muscle cells.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory cell and molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ee1963d3b9bc85abf54aec0eeb465193"><gtr:id>ee1963d3b9bc85abf54aec0eeb465193</gtr:id><gtr:otherNames>Peel SE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1044-1549</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/3B1BA9A0-7562-498D-A95F-B234CFD33806"><gtr:id>3B1BA9A0-7562-498D-A95F-B234CFD33806</gtr:id><gtr:title>A biomechanical model of agonist-initiated contraction in the asthmatic airway.</gtr:title><gtr:parentPublicationTitle>Respiratory physiology &amp; neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/bcb0106ebd2103ffcf71b4965b280d19"><gtr:id>bcb0106ebd2103ffcf71b4965b280d19</gtr:id><gtr:otherNames>Brook BS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1569-9048</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/50D1F4B0-0BA2-4204-AB5B-2BDEE7AEDCAA"><gtr:id>50D1F4B0-0BA2-4204-AB5B-2BDEE7AEDCAA</gtr:id><gtr:title>cAMP regulation of airway smooth muscle function.</gtr:title><gtr:parentPublicationTitle>Pulmonary pharmacology &amp; therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/8568a3bba5378fa6f462b628a756e972"><gtr:id>8568a3bba5378fa6f462b628a756e972</gtr:id><gtr:otherNames>Billington CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1094-5539</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A0F1B598-9AF9-4813-B94B-05B104A00037"><gtr:id>A0F1B598-9AF9-4813-B94B-05B104A00037</gtr:id><gtr:title>The role of inflammation resolution speed in airway smooth muscle mass accumulation in asthma: insight from a theoretical model.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/24cf4e4a5662016da1e9f3c6d3383ea9"><gtr:id>24cf4e4a5662016da1e9f3c6d3383ea9</gtr:id><gtr:otherNames>Chernyavsky IL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/2011218D-02BC-4AD1-B051-0FFB374A0F3F"><gtr:id>2011218D-02BC-4AD1-B051-0FFB374A0F3F</gtr:id><gtr:title>Clonally expanded human airway smooth muscle cells exhibit morphological and functional heterogeneity.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8e269fe7aa9301b7a60b253a54dc27e"><gtr:id>d8e269fe7aa9301b7a60b253a54dc27e</gtr:id><gtr:otherNames>Singh SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/EA0871C3-CC7D-41D6-8450-D8B0BE073C2E"><gtr:id>EA0871C3-CC7D-41D6-8450-D8B0BE073C2E</gtr:id><gtr:title>Can lineage-specific markers be identified to characterize mesenchyme-derived cell populations in the human airways?</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Lung cellular and molecular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d8e269fe7aa9301b7a60b253a54dc27e"><gtr:id>d8e269fe7aa9301b7a60b253a54dc27e</gtr:id><gtr:otherNames>Singh SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1040-0605</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/84F7ABBB-1F20-44E8-93C0-0EB192CE714F"><gtr:id>84F7ABBB-1F20-44E8-93C0-0EB192CE714F</gtr:id><gtr:title>Reverse mode Na+/Ca2+ exchange mediated by STIM1 contributes to Ca2+ influx in airway smooth muscle following agonist stimulation.</gtr:title><gtr:parentPublicationTitle>Respiratory research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a4377ed4861af442d6d8939bfb897ce6"><gtr:id>a4377ed4861af442d6d8939bfb897ce6</gtr:id><gtr:otherNames>Liu B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1465-9921</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/63BD1705-4129-4D69-A2D9-6C17019C1C58"><gtr:id>63BD1705-4129-4D69-A2D9-6C17019C1C58</gtr:id><gtr:title>Nickel induces intracellular calcium mobilization and pathophysiological responses in human cultured airway epithelial cells.</gtr:title><gtr:parentPublicationTitle>Chemico-biological interactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93d7a138f84a871b0a59534315a767a7"><gtr:id>93d7a138f84a871b0a59534315a767a7</gtr:id><gtr:otherNames>Cortijo J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0009-2797</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/6E94EC2F-5103-4142-833A-A132D6E672D7"><gtr:id>6E94EC2F-5103-4142-833A-A132D6E672D7</gtr:id><gtr:title>IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.</gtr:title><gtr:parentPublicationTitle>The Journal of allergy and clinical immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/63ff2ec91e39761c3b838f4287d94b6e"><gtr:id>63ff2ec91e39761c3b838f4287d94b6e</gtr:id><gtr:otherNames>Barlow JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0091-6749</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0701390</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>E3CED108-9B11-45C4-A81B-3730D641CA68</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Respiratory</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>